FDA news. Price criticized for new anti-HIV drug.
The FDA approved a new class of anti-HIV drugs that will benefit patients whose virus has become resistant to other treatments. But as states are facing funding shortfalls for AIDS drug assistance programs, activists say most patients won't be able to afford the drug.